WaveMan · Form 4
Theuer Charles insider trades
> Search tickers & screens ⌘K
LIVE

Theuer Charles insider trades

Theuer Charles has filed 34 Form 4s with the SEC that we hold, for TCON (PRESIDENT AND CEO, Director), 4D Molecular Therapeutics, Inc. (FDMT) (Director) and ONCT (Director). Across all of them we count 27 purchases worth $273.3K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 47,000 shares of TCON worth $35.2K, dated 2023-04-27. The first filing on our record is dated 2021-08-18 and the latest 2026-06-18.

TCON

PRESIDENT AND CEO, Director · 25 filings · 27 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-16P, purchase reported on Form 43,000$10.7K2021-08-18
2021-11-05P, purchase reported on Form 41,000$3.4K2021-11-09
2021-11-05P, purchase reported on Form 43,000$10.3K2021-11-09
2021-11-18P, purchase reported on Form 4681$2.0K2021-11-22
2021-11-19P, purchase reported on Form 43,500$9.9K2021-11-22
2022-03-21P, purchase reported on Form 41,200$2.9K2022-03-23
2022-03-30P, purchase reported on Form 44,000$10.8K2022-04-01
2022-04-08P, purchase reported on Form 42,000$5.0K2022-04-12
2022-04-21P, purchase reported on Form 44,500$10.3K2022-04-25
2022-04-29P, purchase reported on Form 45,000$9.8K2022-05-03
2022-05-06P, purchase reported on Form 42,500$4.9K2022-05-10
2022-05-09P, purchase reported on Form 410,000$18.5K2022-05-11
2022-07-12P, purchase reported on Form 43,000$5.6K2022-07-14
2022-07-13P, purchase reported on Form 43,000$5.5K2022-07-14
2022-07-22P, purchase reported on Form 44,500$8.3K2022-07-25
2022-09-22P, purchase reported on Form 45,000$8.8K2022-09-26
2022-10-03P, purchase reported on Form 45,000$8.3K2022-10-05
2022-10-07P, purchase reported on Form 45,000$8.8K2022-10-11
2022-11-02P, purchase reported on Form 46,000$9.5K2022-11-03
2022-11-03P, purchase reported on Form 49,200$14.0K2022-11-04
2022-11-18P, purchase reported on Form 413,900$19.6K2022-11-22
2022-12-14P, purchase reported on Form 423,000$29.7K2022-12-15
2023-01-18P, purchase reported on Form 46,800$11.0K2023-01-19
2023-02-28P, purchase reported on Form 4200$3042023-03-02
2023-03-01P, purchase reported on Form 44,800$7.3K2023-03-02
2023-04-26P, purchase reported on Form 43,999$2.6K2023-04-28
2023-04-27P, purchase reported on Form 447,000$35.2K2023-04-28

4D Molecular Therapeutics, Inc. (FDMT)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

ONCT

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1631338) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms